🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌱 𝗪𝗵𝘆 London? Because it’s a global leader in sustainability with a bold goal of net zero carbon by 2030. The city perfectly aligns with our theme of “Nurturing a Sustainable Transplantation Journey” #ESOTcongress #Sustainability w/ @ExCeLLondon go.esot.org/congress2025_g…

see you in London england ❤️ 🇬🇧

Useful formula to determine creatinine dilution in someone who is volume overloaded

Are your #ESOTcongress abstracts ready to shine brightly? Do not miss the deadline of 𝟭𝟰 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 2025. Your voice, our future! BTS Maria Kaisar Clatworthy Lab Krish Menon Stephen Pettit Candice Roufosse Raj Thuraisingham Find out more⤵️ go.esot.org/congress2025_a…

SGLT2 Inhibitor Protective Effects in Lupus Systemic lupus erythematosus (SLE) outcomes were assessed based on whether they received sodium-glucose co-transporter 2 inhibitors (SGLT2i), in the setting of comorbid type 2 diabetes (T2D). buff.ly/48ubYK9

#ttvguide 😊

#Tirzepatide SURMOUNT-1 three year efficacy outcomes just presented at #ObesityWeek2024 👀 📉Sustained weight loss of 22.9% or an average 54lbs over 3 years 🔽94% reduction in risk of progression to diabetes. Number Needed to Treat = 9 🤯 🫀Improvement in metabolic parameters

Treatment of #obesity = End of type 2 #diabetes #OW2024 #tirzepatide

SAFE-D finally published: In a short-term feasability study, VKA again turns out to be a "No-Go" in CKD G5-AF, and no OAC seems more attractive than apixaban (admittedly, with a 2 * 5 mg option, while we favor 2 * 2,5 mg). Thanks, Brendan Sunil Badve matthewweir Ron Wald

😳

On #WorldScienceDay we celebrate the amazing scientists in #TTVguide! 👏 They’re using the Torque Teno Virus (#TTV) to help personalize immunosuppressive treatments for #kidney #transplant patients, improving outcomes & reducing risks. 🌍💙 Let’s recognize the power of #science🔬

Gustav Klimts’ monumental “Medicine” was destroyed during National Socialism and has now been reconstructed at the Medical University of Vienna 🇦🇹 😊

We've already seen remarkable results for lupus and other autoimmune diseases with CD19 B cell depletion therapy. Now add IgG4 related disease (which has no treatment) in a new randomized trial NEJM nejm.org/doi/full/10.10…

Important care gap highlighted by the EMPA KIDNEY post-trial follow up: 1 in 4 people with diabetes on SGLT2i who were hospitalised for #heartfailure didnt restart SGLT2i within 12 months of discharge SGLT2i discontinuation analysis led by Tamie Milder: dom-pubs.onlinelibrary.wiley.com/doi/10.1111/do…

Another GLP-1 drug success. Tirzepatide in heart failure with preserved ejection fraction (HFpEF) with longer term follow-up than 2 previous trials with semaglutide nejm.org/doi/full/10.10… NEJM #AHA24 in people with BMI >30; no data yet for HFpEF in people without obesity

Wonderful talk of Frederik Haupenthal about adherence in kidney transplantation. TTV measurements might also help in management! Eagerly awaiting the #TTVGuide results!

#ttvguide

very well deserved: congrats to my colleague katharina mayer 💪

very well deserved Konsti